Chia-Ing Jan - China Medical University Hospital

基本信息

Career Trajectory

Bio

Chia-Ing Jan currently works at the Division of Molecular Pathology, Department of Pathology, China Medical University Hospital. Chia-Ing does research in Oncology, Pathology, Otolaryngology, and Neuro-Oncology. Their most recent publication is 'Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma'.

Research Interests

Papers共 57 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Lower Level of Mir-34A Leads to Placenta Accreta Spectrum by Promoting the Proliferation, Migration of Trophoblast Villous Epithelial Cells and Enhanced the Angiogenesis of Vascular Endothelial Cells

Te-Yao Hsu,Chih-Chang Tsai,Hsin-Hsin Cheng, Kuo-Chung Lan,Hsuan-Ning Hung, Wan-Ting Huang,Yun-Ju Lai,Kun-Long Huang,Huey-Ling You, Ping-Chung Tsai,Chia-Ing Jan,Sung-Chou Li

PLACENTA（2025）

Cited0Views0WOSBibtex

Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion

Yi-Ming Chang,Wen-Yen Huang,Shih-Hsien Yang,Chia-Ing Jan,Shin Nieh,Yaoh-Shiang Lin,Su-Feng Chen,Yu-Chun Lin

Cellsno. 11 (2024): 968-968

Cited0Views0WOSBibtex

Identifying Prognostic Predictors for Postoperative Pituitary Neuroendocrine Tumour Recurrence: an Integrated Clinical, Radiological, and Immunohistochemistry Assessment

Chia-Yu Chen,Jin-Shuen Chen,Yao-Shen Chen,Chun-Hao Yin,Chia-Ing Jan,Shuo-Hsiu Hsu,Yao-Chung Yang,Wei-Chuan Liao

British Journal of Neurosurgery（2024）

Cited0Views0WOSBibtex

Supplementary Figure 4 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation

Chi-Yuan Chen,Chia-Ing Jan,Jeng-Fan Lo,Shuenn-Chen Yang,Yih-Leong Chang,Szu-Hua Pan,Wen-Lung Wang,Tse-Ming Hong,Pan-Chyr Yang

openalex（2023）

Cited0Views0Bibtex

Artificial Intelligence-Based Cancer Progression Prediction of Oral Premalignant Lesions Via Self-Supervised Deep Learning on Histopathology

Siddhi Ramesh,James M Dolezal,Sara Kochanny,Emily Lanzel,Yih-Leong Chang, Chen-Tu Wu,Chia-Ing Jan,Tseng-Cheng Chen,Chun-Hung Hua,Chung-Jan Kang,Chih-Yen Chien,Ming-Hsui Tsai,Cheng-Ping Wang,Nishant Agrawal,Evgeny Izumchenko,Kelly Yu,John Hellstein,Mark W. Lingen,Anil Chaturvedi,Alexander T. Pearson

JCO Global Oncologyno. Supplement_1 (2023): 90-90

Cited0Views0Bibtex

Supplementary Table 2 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation

Chi-Yuan Chen,Chia-Ing Jan,Jeng-Fan Lo,Shuenn-Chen Yang,Yih-Leong Chang,Szu-Hua Pan,Wen-Lung Wang,Tse-Ming Hong,Pan-Chyr Yang

openalex（2023）

Cited0Views0Bibtex

CAR-T Cells Targeting HLA-G As Potent Therapeutic Strategy for EGFR-mutated and Overexpressed Oral Cancer

Yu-Chuan Lin,Chun-Hung Hua,Hsin-Man Lu,Shi-Wei Huang,Yeh Chen,Ming-Hsui Tsai,Fang-Yu Lin,Peter Canoll,Shao-Chih Chiu, Wei-Hua Huang,Der-Yang Cho,Chia-Ing Jan

ISCIENCE（2023）

Cited2Views0WOSBibtex

Supplementary Methods, Figure Legends 1-6, Table Legend 1 from the Epithelial-Mesenchymal Transition Mediator S100A4 Maintains Cancer-Initiating Cells in Head and Neck Cancers

Jeng-Fan Lo,Cheng-Chia Yu,Shih-Hwa Chiou,Chih-Yang Huang,Chia-Ing Jan,Shu-Chun Lin,Chung-Ji Liu,Wen-Yuan Hu,Yau-Hua Yu

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 1 from Tid1-L Inhibits EGFR Signaling in Lung Adenocarcinoma by Enhancing EGFR Ubiquitinylation and Degradation

Chi-Yuan Chen,Chia-Ing Jan,Jeng-Fan Lo,Shuenn-Chen Yang,Yih-Leong Chang,Szu-Hua Pan,Wen-Lung Wang,Tse-Ming Hong,Pan-Chyr Yang

crossref（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn